$64.46
1.45%
Nasdaq, Sep 24, 04:00 pm EDT. Closed.
ISIN
US30214U1025
Symbol
EXPO

Exponent, Inc. Target price 2026 - Analyst rating & recommendation

Exponent, Inc. Classifications & Recommendation

Buy
80%
Hold
20%

Exponent, Inc. Price Target

Target Price $82.62
Price $64.46
Potential
Number of Estimates 5
5 Analysts have issued a price target Exponent, Inc. 2027 . The average Exponent, Inc. target price is $82.62. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 10 analysts: 8 Analysts recommend Exponent, Inc. to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Exponent, Inc. stock has an average upside potential 2027 of . Most analysts recommend the Exponent, Inc. stock at Purchase.

Sales and Margin forecast 2027, 2028 & 2029

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Jan '26 2027
Estimates
Revenue Million $ 582.01 671.13
4.21% 15.31%
EBITDA Margin 22.31% 29.89%
3.58% 33.95%
Net Margin 18.21% 19.43%
6.67% 6.67%

6 Analysts have issued a sales forecast Exponent, Inc. 2027 . The average Exponent, Inc. sales estimate is

$671m
unlock
. This is
11.33% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$761m 26.28%
unlock
, the lowest is
$620m 2.92%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2026 $582m 4.21%
2027
$671m 15.31%
unlock
2028
$731m 8.97%
unlock

6 Analysts have issued an Exponent, Inc. EBITDA forecast 2027. The average Exponent, Inc. EBITDA estimate is

$201m
unlock
. This is
58.18% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$229m 80.46%
unlock
, the lowest is
$178m 40.07%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2026 $130m 0.48%
2027
$201m 54.49%
unlock
2028
$222m 10.46%
unlock

EBITDA Margin

2026 22.31% 3.58%
2027
29.89% 33.95%
unlock
2028
30.30% 1.37%
unlock

6 Exponent, Inc. Analysts have issued a net profit forecast 2027. The average Exponent, Inc. net profit estimate is

$130m
unlock
. This is
19.74% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$139m 27.48%
unlock
, the lowest is
$123m 12.85%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2026 $106m 2.74%
2027
$130m 23.04%
unlock
2028
$142m 8.74%
unlock

Net Margin

2026 18.21% 6.67%
2027
19.43% 6.67%
unlock
2028
19.39% 0.21%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 & 2029

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Jan '26 2027
Estimates
Earnings Per Share $ 2.07 2.68
1.90% 29.47%
P/E 24.03
EV/Sales 4.39

6 Analysts have issued a Exponent, Inc. forecast for earnings per share. The average Exponent, Inc. EPS is

$2.68
unlock
. This is
23.50% higher
unlock
than earnings per share in the financial year 2026. The highest EPS forecast is
$2.86 31.80%
unlock
, the lowest is
$2.53 16.59%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2026 $2.07 1.90%
2027
$2.68 29.47%
unlock
2028
$2.92 8.96%
unlock

P/E ratio

Current 29.71 14.75%
2027
24.03 19.10%
unlock
2028
22.10 8.03%
unlock

Based on analysts' sales estimates for 2027, the Exponent, Inc. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 4.89 16.12%
2027
4.39 10.22%
unlock
2028
4.03 8.23%
unlock

P/S ratio

Current 5.08 18.62%
2027
4.57 10.18%
unlock
2028
4.19 8.24%
unlock

Current Exponent, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
JP Morgan
Locked
➜
Locked
Locked Jul 31 2026
UBS
Locked
➜
Locked
Locked Jul 31 2026
JP Morgan
Locked
➜
Locked
Locked May 15 2026
UBS
Locked
➜
Locked
Locked May 01 2026
JP Morgan
Locked
➜
Locked
Locked Mar 26 2026
JP Morgan
Locked
➜
Locked
Locked Jan 26 2026
UBS
Locked
➜
Locked
Locked Dec 15 2025
Analyst Rating Date
Locked
JP Morgan:
Locked
➜
Locked
Jul 31 2026
Locked
UBS:
Locked
➜
Locked
Jul 31 2026
Locked
JP Morgan:
Locked
➜
Locked
May 15 2026
Locked
UBS:
Locked
➜
Locked
May 01 2026
Locked
JP Morgan:
Locked
➜
Locked
Mar 26 2026
Locked
JP Morgan:
Locked
➜
Locked
Jan 26 2026
Locked
UBS:
Locked
➜
Locked
Dec 15 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today